NCT05571696Completed
Mind Matters: A High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients With Psoriatic Diseases
Source: ClinicalTrials.gov · Last updated 6 Oct 2025
Brief summary (registry, in English)
Despite advances in effective psoriatic disease treatment, the disease still has a serious impact on mental health and well-being of millions of patients. Up to 20.7% of patients report poor mental health, compared to 7.1% of the general population. Mental health treatment involves a combination of medication and talk therapy to address such issues. However, there is increasing evidence that optimizing behaviors such as sleep, physical activity, stress, and nutrition are critical components in improving mental health too. Numerous online health programs have evolved to help patients optimize such behaviors but very little exists for patients with psoriatic diseases. The "Immune Strength" 12 week program utilizes online electronic coaching (eCoaching) with weekly access to a wellness professional to provide a low-cost, high-touch, personalized intervention that patients can access 24/7. In conjunction with traditional clinical care, the goal of this program is to leverage the convenience, affordability, scalability and effectiveness of an online eCoaching program to improve key physical behaviors, thereby reducing the mental health burden experienced by psoriatic disease patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 84 (actual)
- First submitted
- 26 Jul 2022
- Start date
- 27 Oct 2022
- Primary completion date
- 31 Mar 2025
- Lead sponsor
- Elaine Husni
- Diseases
- Psoriasis, Psoriatic arthritis
- NCT number
- NCT05571696
What you commit to
- Study type: Interventional
- Participants enrolled: 84
- From 27 Oct 2022 to the primary completion date, 31 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently receiving psychotherapy for major depressive disorder (MDD), anxiety or psychotic disorder
- Received treatment for a severe psychiatric illness in the previous 6 months
Other illness
- History of major depressive disorder
Other
- PHQ9 score \> 20
- On a wait-list for psychotherapeutic treatment
- Demonstrate a notable suicidal risk at study visit
Who the study is looking for
- Patient of Cleveland Clinic
- Adults (=18 years of age)
- Diagnosis of psoriasis or psoriatic arthritis by a board certified physician.
- PHQ9 score between 5 and 20
- Computer and internet access
- A valid email address
- Able to speak \& read English
- Able to understand \& sign informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Cleveland Clinic Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.